Pattern of statin use in southern Italian primary care: Can prescription databases be used for monitoring long-term adherence to the treatment?

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Ferrajolo, Carmen ^a,b   Arcoraci, Vincenzo ^c   Sullo, Maria Giuseppa ^a   Rafaniello, Concetta ^a   Sportiello, Liberata ^a   Ferrara, Rosarita ^c   Cannata, Angelo ^c   Pagliaro, Claudia ^d   Tari, Michele Giuseppe ^d   Caputi, Achille Patrizio ^b   Rossi, Francesco ^a   Trifirò, Gianluca ^b,c   Capuano, Annalisa ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MESSINA   (Italy)

^d Caserta 1 Local Health Service   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; EZETIMIBE PLUS SIMVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DRUG COST; DRUG USE; DRUG UTILIZATION; FEMALE; HEALTH CARE POLICY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; ITALY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PROBABILITY; REIMBURSEMENT; RESIDENTIAL CARE; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SEX DIFFERENCE; SOUTHERN ITALY; AGED; FACTUAL DATABASE; FOLLOW UP; HEALTH SURVEY; MEDICATION COMPLIANCE; MIDDLE AGED; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DATABASES, FACTUAL; DRUG UTILIZATION REVIEW; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; ITALY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRESCRIPTIONS; PREVALENCE; PRIMARY HEALTH CARE; PUBLIC HEALTH SURVEILLANCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84905054125     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102146     Document Type: Article

References (53)

1. Nichols M, Townsend N, Scarborough P, Rayner M (2013) Cardiovascular disease in Europe: epidemiological update. Eur Heart J 34: 3028-3034.
2. Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, et al. (2013) Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 1: CD004816.
3. OSMED Gdl (2012) L'uso dei farmaci in Italia: rapporto nazionale anno 2011. Il Pensiero Scientifico Editore. Available: http://www.iss.it/binary/pres/ cont/osmed-2011.pdf. Accessed 2014 Jul 9.
4. Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, et al. (2011) ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 217: 3-46.
5. Agenxia Italiana del Farmaco (2004) Note AIFA 204: Revisione delle Note CUF. Available: http://www.agenziafarmaco.gov.it/wscs-render-attachment-by-id/ 111.22286.11382709905685963.pdf?id=111.22295.1138270991779. Accessed 2014 Jul 9.
6. Regione Campania (2008) Bollettino Ufficiale: Piano di contenimento della spesa farmaceutica. Promozione dell'appropriatezza diagnostica e terapeutica nelle dislipidemie e dei farmaci equivalenti nella classe C10AA degli inibitori dell'HGM-CoA Reduttasi. Available: http://www.sito.regione.campania.it/burc/ pdf08/burc53or-08/del1883-08.pdf. Accessed 2014 Jul 9.
7. Poluzzi E, Piccinni C, Carta P, Puccini A, Lanzoni M, et al. (2011) Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study. Eur J Clin Pharmacol 67: 407-414.
8. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, et al. (1998) Persistence of use of lipid-lowering medications: a cross-national study. JAMA 279: 1458-1462. (Pubitemid 28228203)
9. Jackevicius CA, Mamdani M, Tu JV (2002) Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288: 462-467. (Pubitemid 34787477)
10. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, et al. (2002) Long-term persistence in use of statin therapy in elderly patients. JAMA 288: 455-461. (Pubitemid 34787476)
11. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW (2002) Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40: 794-811.
12. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA (2011) Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood) 30: 91-99.
13. Schedlbauer A, Davies P, Fahey T (2010) Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev: CD004371.
14. Lemstra M, Blackburn D, Crawley A, Fung R (2012) Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis. Can J Cardiol 28: 574-580.
15. Alacqua M, Trifiro G, Cavagna L, Caporali R, Montecucco CM, et al. (2008) Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal. Arthritis Rheum 59: 568-574. (Pubitemid 351563541)
16. Alacqua M, Trifiro G, Spina E, Moretti S, Tari DU, et al. (2009) Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. Epilepsy Res 85: 107-113.
17. Oteri A, Trifiro G, Gagliostro MS, Tari DU, Moretti S, et al. (2010) Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07. Br J Clin Pharmacol 70: 514-522.
18. Piacentini N, Trifiro G, Tari M, Moretti S, Arcoraci V (2005) Statin-macrolide interaction risk: a population-based study throughout a general practice database. Eur J Clin Pharmacol 61: 615-620. (Pubitemid 41414246)
19. Trifiro G, Alacqua M, Corrao S, Moretti S, Tari DU, et al. (2008) Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision. Eur J Clin Pharmacol 64: 619-625.
20. Trifiro G, Alacqua M, Corrao S, Tari M, Arcoraci V (2008) Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials. J Am Geriatr Soc 56: 175-177.
21. Trifiro G, Barbui C, Spina E, Moretti S, Tari M, et al. (2007) Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Pharmacoepidemiol Drug Saf 16: 552-559. (Pubitemid 46824277)
22. Trifiro G, Corrao S, Alacqua M, Moretti S, Tari M, et al. (2006) Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources. Br J Clin Pharmacol 62: 582-590. (Pubitemid 44571580)
23. Trifiro G, Italiano D, Alibrandi A, Sini G, Ferrajolo C, et al. (2013) Effects of L'Aquila earthquake on the prescribing pattern of antidepressant and antipsychotic drugs. Int J Clin Pharm 35: 1053-1062.
24. Trifiro G, Morgante L, Tari M, Arcoraci V, Savica R (2008) Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agent. J Am Geriatr Soc 56: 371-373. (Pubitemid 351160673)
25. Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, et al. (2007) A checklist for medication compliance and persistence studies using retrospective databases. Value Health 10: 3-12. (Pubitemid 46161090)
26. Pittman DG, Chen W, Bowlin SJ, Foody JM (2011) Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol 107: 1662-1666.
27. Trifiro G, Spina E, Brignoli O, Sessa E, Caputi AP, et al. (2005) Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002. Eur J Clin Pharmacol 61: 47-53. (Pubitemid 40558279)
28. Corrao G, Conti V, Merlino L, Catapano AL, Mancia G (2010) Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Clin Ther 32: 300-310.
29. Walley T, Folino-Gallo P, Schwabe U, van Ganse E (2004) Variations and increase in use of statins across Europe: data from administrative databases. BMJ 328: 385-386. (Pubitemid 38241189)
30. Walley T, Folino-Gallo P, Stephens P, Van Ganse E (2005) Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003. Br J Clin Pharmacol 60: 543-551. (Pubitemid 41532455)
31. OSMED GdL (2005) L'uso dei farmaci in Italia: rapporto nazionale anno 2004. Il Pensiero Scientifico Editore. Available: http://www.epicentro.iss.it/ farmaci/pdf/OsMed/OsMed%202005.pdf. Accessed 2014 Jul 9.
32. OSMED GdL (2006) L'uso dei farmaci in Italia: rapporto nazionale anno 2005. Il Pensiero Scientifico Editore.
33. OSMED GdL (2007) L'uso dei farmaci in Italia: rapporto nazionale anno 2006. Il Pensiero Scientifico Editore.
34. OSMED GdL (2008) L'uso dei farmaci in Italia: rapporto nazionale anno 2007. Il Pensiero Scientifico Editore. Available: http://www.agenziafarmaco.gov. it/allegati/rapporto-osmed-2007.pdf Accessed 2014 Jul 9.
35. OSMED GdL (2009) L'uso dei farmaci in Italia: rapporto nazionale anno 2008. Il Pensiero Scientifico Editore. Available: http://www.agenziafarmaco.gov. it/allegati/rapporto-osmed-2008.pdf. Accessed 2014 Jul 9.
36. OSMED GdL (2010) L'uso dei farmaci in Italia: rapporto nazionale anno 2009. Il Pensiero Scientifico Editore. Available: http://www.epicentro.iss.it/ farmaci/pdf/OsMed/Osmed2009.pdf. Accessed 2014 Jul 9.
37. OSMED GdL (2011) L'uso dei farmaci in Italia: rapporto nazionale anno 2010. Il Pensiero Scientifico Editore. Available: http://www.epicentro.iss.it/ farmaci/pdf/OsMed/Osmed%202010.pdf. Accessed 2014 Jul 9.
38. Gnavi R, Migliardi A, Demaria M, Petrelli A, Caprioglio A, et al. (2007) Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities. Eur J Public Health 17: 492-496. (Pubitemid 350033999)
39. Deambrosis P, Saramin C, Terrazzani G, Scaldaferri L, Debetto P, et al. (2007) Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003. Eur J Clin Pharmacol 63: 197-203. (Pubitemid 46147062)
40. Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, et al. (2004) [Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score]. Ann Ist Super Sanita 40: 393-399.
41. Isles CG, Hole DJ, Hawthorne VM, Lever AF (1992) Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet 339: 702-706.
42. Savoie I, Kazanjian A (2002) Utilization of lipid-lowering drugs in men and women. a reflection of the research evidence? J Clin Epidemiol 55: 95-101. (Pubitemid 34040998)
43. Walsh JM, Pignone M (2004) Drug treatment of hyperlipidemia in women. JAMA 291: 2243-2252. (Pubitemid 38608174)
44. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, et al. (2007) Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 115: 1481-1501. (Pubitemid 46648385)
45. Saib A, Sabbah L, Perdrix L, Blanchard D, Danchin N, et al. (2013) Evaluation of the impact of the recent controversy over statins in France: The EVANS study. Arch Cardiovasc Dis 106: 511-516.
46. Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M (2010) Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis. Int J Cardiol 138: 25-31.
47. Naci H, Brugts JJ, Fleurence R, Ades AE (2013) Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials. QJM 106: 299-306.
48. Kozyrskyj A, Raymond C, Racher A (2007) Characterizing early prescribers of newly marketed drugs in Canada: a population-based study. Eur J Clin Pharmacol 63: 597-604. (Pubitemid 46684483)
49. Degli Esposti L, Saragoni S, Batacchi P, Benemei S, Geppetti P, et al. (2012) Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis. Clin Ther 34: 190-199.
50. Wei MY, Ito MK, Cohen JD, Brinton EA, Jacobson TA (2013) Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education. J Clin Lipidol 7: 472-483.
51. Capuano A, Irpino A, Gallo M, Ferrante L, Illiano ML, et al. (2009) Regional surveillance of emergency-department visits for outpatient adverse drug events. Eur J Clin Pharmacol 65: 721-728.
52. Capuano A, Motola G, Russo F, Avolio A, Filippelli A, et al. (2004) Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharmacol Res 50: 631-636. (Pubitemid 39388975)
53. Mazzitello C, Esposito S, De Francesco AE, Capuano A, Russo E, et al. (2013) Pharmacovigilance in Italy: An overview. J Pharmacol Pharmacother 4: S20-S28.